Alkem Laboratories Ltd. v. Iheal Pharmaceutical
Case brief
What is this about?
Consent decree on admission; trademark infringement and passing off settled: Alkem Laboratories Ltd. v. Iheal Pharmaceuticals, COMMERCIAL IP SUIT NO.356 OF 2025, Bombay High Court Commercial Division, Sharmila U. Deshmukh, J., MAY 8, 2026. Dispute amicably settled; Consent Terms accepted as undertakings; suit decreed per prayers (a) and (b): perpetual injunction restraining Defendant from use of 'OMEDEE' and marks identical/deceptively similar to 'OMEE' and 'OMEE family of marks'; refund of Court fees as per rules; Interim Application No.5395 OF 2025 and INTERIM APPLICATION (L) NO.15616 OF 2026 (NOT ON BOARD) disposed. Keywords: pharmaceutical marks, consent terms, decree on admission, undertaking to Court, perpetual injunction, OMEDEE/OMEE.
What did the court decide?
Consent decree on admission: perpetual injunctions per prayer clauses (a) and (b) restraining Iheal Pharmaceuticals and its Partners, employees, dealers, licensees, affiliates, assigns and all persons acting on its behalf from using the trade mark 'OMEDEE' or any mark identical with/deceptively similar to the registered trade marks 'OMEE' and 'OMEE family of marks' (24 registration numbers listed), whether so as to infringe or so as to pass off the Defendant's goods as the Plaintiff's or indicate connection with the Plaintiff; refund of Court fees as per rules; Interim Applications stand disposed of.